Search
for
Sort by
Research 151–180 of 1000+
- Association of Insulin Resistance with Hyperandrogenia in Women
- Efficacy and safety of SGLT2 inhibitor on insulin resistance and hyperglycemia in Werner syndrome—A case report
- Plasma Diaphanous Related Formin 1 Levels Are Associated with Altered Glucose Metabolism and Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Case Control Study
- Medical treatment regimens of hirsutism
- PCOS in adolescents
- Pharmacotherapy of polycystic ovary syndrome - an update
- Exploring the Antioxidative Effects of Ginger and Cinnamon: A Comprehensive Review of Evidence and Molecular Mechanisms Involved in Polycystic Ovary Syndrome (PCOS) and Other Oxidative Stress-Related Disorders
- Menstrual Cycle Alterations during Adolescence: Early Expression of Metabolic Syndrome and Polycystic Ovary Syndrome
- The Role of Probiotics and Synbiotics on Hirsutism
- Polycystic Ovary Syndrome and Oxidative Stress—From Bench to Bedside
- Polycystic Ovarian Syndrome
- AN UPDATED OVERVIEW OF POLYCYSTIC OVARY SYNDROME
- Polycystic Ovarian Syndrome: A Breakthrough Etiology, Symptoms and Therapy
- CURRENT THERAPEUTIC APPROACHES IN THE MANAGEMENT OF POLYCYSTIC OVARY SYNDROME
- Functional Ingredient Mapping in PCOS Formulations: Hormonal Excess
- ROLE OF METFORMIN AND VITAMIN D3 IN OBESE PCOS PATIENTS
- Serum irisin level in patients with acne vulgaris
- Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
- NEW PROPRIETARY BRANDS: Cefaclor monohydrate
- The SAHA Syndrome
- A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2
- Comparative evaluation of sonographic ovarian morphology of Indian women with polycystic ovary syndrome versus those of normal women
- Hirsutism in Children: A Comprehensive Review of Etiology, Clinical Evaluation and Contemporary Management
- NEDD4 Transcript Variant 3 and IGF-1 as Molecular Markers in the Development and Prognosis of Keloids
- Hirsutism
- Androgenetic alopecia as a cardiovascular risk factor
- Obesity and polycystic ovary syndrome
- Biochemical predictor for polycystic ovary syndrome
- Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
- 11β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes